132 related articles for article (PubMed ID: 38481588)
21. Is PSA density of the peripheral zone as a useful predictor for prostate cancer in patients with gray zone PSA levels?
Lee J; Yang SW; Jin L; Lee CL; Lee JY; Shin JH; Lim JS; Song KH
BMC Cancer; 2021 Apr; 21(1):472. PubMed ID: 33910525
[TBL] [Abstract][Full Text] [Related]
22. [Comparison of prostate volume measured by transrectal and abdominal echography and its implication for the measurement of the PSA density for the diagnosis of prostate cancer].
Rodríguez-Patrón Rodríguez R; Mayayo Dehesa T; Lennie Zucharino A; González Galán A
Arch Esp Urol; 2002 Sep; 55(7):797-806. PubMed ID: 12380308
[TBL] [Abstract][Full Text] [Related]
23. The potential role of prebiopsy magnetic resonance imaging combined with prostate-specific antigen density in the detection of prostate cancer.
Kubota Y; Kamei S; Nakano M; Ehara H; Deguchi T; Tanaka O
Int J Urol; 2008 Apr; 15(4):322-6; discussion 327. PubMed ID: 18380820
[TBL] [Abstract][Full Text] [Related]
24. Utility of the transition zone index for identification of prostate cancer in Chinese men with intermediate PSA levels.
Qi TY; Chen YQ; Jiang J; Zhu YK; Yao XH; Wang XJ
Int Urol Nephrol; 2012 Jun; 44(3):807-15. PubMed ID: 22311386
[TBL] [Abstract][Full Text] [Related]
25. An algorithm for prostate cancer detection in a patient population using prostate-specific antigen and prostate-specific antigen density.
Benson MC; McMahon DJ; Cooner WH; Olsson CA
World J Urol; 1993; 11(4):206-13. PubMed ID: 7508785
[TBL] [Abstract][Full Text] [Related]
26. Volume-adjusted prostate-specific antigen (PSA) variables in detecting impalpable prostate cancer in men with PSA levels of 2-4 ng/mL: transabdominal measurement makes a significant contribution.
Kobayashi T; Kawahara T; Nishizawa K; Ogura K; Mitsumori K; Ide Y
BJU Int; 2005 Jun; 95(9):1245-8. PubMed ID: 15892809
[TBL] [Abstract][Full Text] [Related]
27. The use of prostate specific antigen (PSA) density in detecting prostate cancer in Chinese men with PSA levels of 4-10 ng/mL.
Zheng XY; Xie LP; Wang YY; Ding W; Yang K; Shen HF; Qin J; Bai Y; Chen ZD
J Cancer Res Clin Oncol; 2008 Nov; 134(11):1207-10. PubMed ID: 18446367
[TBL] [Abstract][Full Text] [Related]
28. Comparison of 6- and 12-core prostate biopsy in Taiwanese men: impact of total prostate-specific antigen, prostate-specific antigen density and prostate volume on prostate cancer detection.
Chiang IN; Chang SJ; Pu YS; Huang KH; Yu HJ; Huang CY
Urol Int; 2009; 82(3):270-5. PubMed ID: 19440012
[TBL] [Abstract][Full Text] [Related]
29. Value of prostate volume measurement using transabdominal ultrasonography for the improvement of prostate-speci fi c antigen-based cancer detection.
Kobayashi T; Kawahara T; Nishizawa K; Ogura K; Mitsumori K; Ide Y
Int J Urol; 2005 Oct; 12(10):881-5. PubMed ID: 16323981
[TBL] [Abstract][Full Text] [Related]
30. [Examination for indication of systematic biopsy for diagnosis of prostate cancer].
Muraoka K; Takahashi C; Yamamoto Y; Watanabe T; Hirakawa S; Miyagawa I
Nihon Hinyokika Gakkai Zasshi; 1999 Jul; 90(7):657-62. PubMed ID: 10481471
[TBL] [Abstract][Full Text] [Related]
31. Value of serum free prostate-specific antigen density in the diagnosis of prostate cancer.
Zou BZ; Wen H; Luo HJ; Luo WC; Xie QT; Zhou MT
Ir J Med Sci; 2023 Dec; 192(6):2681-2687. PubMed ID: 37414978
[TBL] [Abstract][Full Text] [Related]
32. Does prostate-specific antigen density alter decision making on biopsy?
Vleeming R; de Craen AJ; de Reijke TM; van Andel G; Kurth KH
Eur Urol; 1996; 29(1):10-14. PubMed ID: 8821683
[TBL] [Abstract][Full Text] [Related]
33. Prostate specific antigen density can help avoid unnecessary prostate biopsies at prostate specific antigen range of 4-10 ng/ml.
Lodeta B; Benko G; Car S; Filipan Z; Stajcar D; Dujmović T
Acta Clin Croat; 2009 Jun; 48(2):153-5. PubMed ID: 19928413
[TBL] [Abstract][Full Text] [Related]
34. Intermediate versus low or high prostate-specific antigen density level: comparison of cancer detection rate between 12- and 18-core prostate biopsy.
Park HK; Lee KY; Kim KH; Jung H; Yoon SJ; Kim TB
Scand J Urol Nephrol; 2010 Dec; 44(6):391-8. PubMed ID: 20695726
[TBL] [Abstract][Full Text] [Related]
35. Comparison of the predictive accuracy of serum prostate specific antigen levels and prostate specific antigen density in the detection of prostate cancer in Hispanic-American and white men.
Lam JS; Cheung YK; Benson MC; Goluboff ET
J Urol; 2003 Aug; 170(2 Pt 1):451-6. PubMed ID: 12853797
[TBL] [Abstract][Full Text] [Related]
36. Zonal adjusted PSA density improves prostate cancer detection rates compared with PSA in Taiwanese males with PSA < 20 ng/ml.
Chang TH; Lin WR; Tsai WK; Chiang PK; Chen M; Tseng JS; Chiu AW
BMC Urol; 2020 Oct; 20(1):151. PubMed ID: 33028274
[TBL] [Abstract][Full Text] [Related]
37. Predictive value of PSA density in the diagnosis of prostate cancer in lebanese men.
Msheik A; Mohanna M; Mhanna A; Kanj A; Moussa M; Mohanna A
Arch Ital Urol Androl; 2022 Mar; 94(1):18-24. PubMed ID: 35352520
[TBL] [Abstract][Full Text] [Related]
38. Predicting prostate biopsy outcome by findings at digital rectal examination, transrectal ultrasonography, PSA, PSA density and free-to-total PSA ratio in a population-based screening setting.
Ciatto S; Bonardi R; Lombardi C; Cappelli G; Castagnoli A; D'Agata A; Zappa M; Gervasi G
Int J Biol Markers; 2001; 16(3):179-82. PubMed ID: 11605730
[TBL] [Abstract][Full Text] [Related]
39. TRUS Biopsy Yield in Indian Population: A Retrospective Analysis.
Patil SR; Pawar PW; Sawant AS; Patil AV; Narwade SS; Mundhe ST; Savalia AJ; Tamhankar AS
J Clin Diagn Res; 2017 Feb; 11(2):PC01-PC05. PubMed ID: 28384926
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic value of MRI-based PSA density in predicting transperineal sector-guided prostate biopsy outcomes.
MacAskill F; Lee SM; Eldred-Evans D; Wulaningsih W; Popert R; Wolfe K; Van Hemelrijck M; Rottenberg G; Liyanage SH; Acher P
Int Urol Nephrol; 2017 Aug; 49(8):1335-1342. PubMed ID: 28477301
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
